110 related articles for article (PubMed ID: 30259651)
1. Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists.
Wu P; Luo X; Wu H; Yu F; Wang K; Sun M; Oupicky D
Macromol Biosci; 2018 Nov; 18(11):e1800234. PubMed ID: 30259651
[TBL] [Abstract][Full Text] [Related]
2. Cyclam-Modified PEI for Combined VEGF siRNA Silencing and CXCR4 Inhibition To Treat Metastatic Breast Cancer.
Zhou Y; Yu F; Zhang F; Chen G; Wang K; Sun M; Li J; Oupický D
Biomacromolecules; 2018 Feb; 19(2):392-401. PubMed ID: 29350899
[TBL] [Abstract][Full Text] [Related]
3. Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl
Ullah A; Chen G; Hussain A; Khan H; Abbas A; Zhou Z; Shafiq M; Ahmad S; Ali U; Usman M; Raza F; Ahmed A; Qiu Z; Zheng M; Liu D
Int J Nanomedicine; 2021; 16():4451-4470. PubMed ID: 34234436
[TBL] [Abstract][Full Text] [Related]
4. Development of functional poly(amido amine) CXCR4 antagonists with the ability to mobilize leukocytes and deliver nucleic acids.
Wang Y; Hazeldine ST; Li J; Oupický D
Adv Healthc Mater; 2015 Apr; 4(5):729-38. PubMed ID: 25491178
[TBL] [Abstract][Full Text] [Related]
5. CXCR4-Targeted and Redox Responsive Dextrin Nanogel for Metastatic Breast Cancer Therapy.
Zhang F; Gong S; Wu J; Li H; Oupicky D; Sun M
Biomacromolecules; 2017 Jun; 18(6):1793-1802. PubMed ID: 28445650
[TBL] [Abstract][Full Text] [Related]
6. Combined Hydrophobization of Polyethylenimine with Cholesterol and Perfluorobutyrate Improves siRNA Delivery.
Wu P; Luo X; Wu H; Zhang Q; Wang K; Sun M; Oupicky D
Bioconjug Chem; 2020 Mar; 31(3):698-707. PubMed ID: 31967460
[TBL] [Abstract][Full Text] [Related]
7. Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer.
Chen G; Wang Y; Wu P; Zhou Y; Yu F; Zhu C; Li Z; Hang Y; Wang K; Li J; Sun M; Oupicky D
ACS Nano; 2018 Jul; 12(7):6620-6636. PubMed ID: 29985577
[TBL] [Abstract][Full Text] [Related]
8. Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexes.
Wang Y; Li J; Chen Y; Oupický D
Biomater Sci; 2015 Jul; 3(7):1114-23. PubMed ID: 26146552
[TBL] [Abstract][Full Text] [Related]
9. Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric Plerixafor.
Li J; Oupický D
Biomaterials; 2014 Jul; 35(21):5572-9. PubMed ID: 24726746
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 regulates growth of both primary and metastatic breast cancer.
Smith MC; Luker KE; Garbow JR; Prior JL; Jackson E; Piwnica-Worms D; Luker GD
Cancer Res; 2004 Dec; 64(23):8604-12. PubMed ID: 15574767
[TBL] [Abstract][Full Text] [Related]
11. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
12. Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia.
Wang Y; Xie Y; Williams J; Hang Y; Richter L; Becker M; Amador C; Oupický D; Hyde RK
Cancer Gene Ther; 2020 Feb; 27(1-2):45-55. PubMed ID: 31028289
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis.
Ding L; Zhu C; Yu F; Wu P; Chen G; Ullah A; Wang K; Sun M; Li J; Oupický D
Nanomedicine; 2018 Aug; 14(6):1765-1776. PubMed ID: 29777878
[TBL] [Abstract][Full Text] [Related]
14. Photoluminescent and biodegradable polycitrate-polyethylene glycol-polyethyleneimine polymers as highly biocompatible and efficient vectors for bioimaging-guided siRNA and miRNA delivery.
Wang M; Guo Y; Yu M; Ma PX; Mao C; Lei B
Acta Biomater; 2017 May; 54():69-80. PubMed ID: 28219808
[TBL] [Abstract][Full Text] [Related]
15. Fluorination Enhances Serum Stability of Bioreducible Poly(amido amine) Polyplexes and Enables Efficient Intravenous siRNA Delivery.
Chen G; Wang K; Wang Y; Wu P; Sun M; Oupický D
Adv Healthc Mater; 2018 Mar; 7(5):. PubMed ID: 29280311
[TBL] [Abstract][Full Text] [Related]
16. Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis.
Wang Y; Kumar S; Rachagani S; Sajja BR; Xie Y; Hang Y; Jain M; Li J; Boska MD; Batra SK; Oupický D
Biomaterials; 2016 Sep; 101():108-120. PubMed ID: 27267632
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis.
Ma WF; Du J; Fu LP; Fang R; Chen HY; Cai SH
Mol Cancer Res; 2009 Oct; 7(10):1613-21. PubMed ID: 19825996
[TBL] [Abstract][Full Text] [Related]
18. Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions.
Li Z; Chen G; Ding L; Wang Y; Zhu C; Wang K; Li J; Sun M; Oupicky D
Mol Ther; 2019 Dec; 27(12):2100-2110. PubMed ID: 31481310
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of murine breast cancer growth and metastasis by survivin-targeted siRNA using disulfide cross-linked linear PEI.
Liu S; Huang W; Jin MJ; Fan B; Xia GM; Gao ZG
Eur J Pharm Sci; 2016 Jan; 82():171-82. PubMed ID: 26554721
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA in nude mice model of ovarian cancer.
Liu W; Wang Y; Wang H; Wang A
Cell Biochem Biophys; 2014 Dec; 70(3):1893-900. PubMed ID: 25149650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
